About Us

A highly experienced management team, supported by world class academic founders and top tier Board.

Sitryx Pioneers of Immunometabolism

Leadership Team

An experienced team of drug hunters and developers. Our senior management team have a proven track record of guiding new companies through early inflection points and collectively has overseen 40+ new molecular entities through candidate nomination into development.
Neil WeirCEO
Iain KiltyCSO
Jonathan SeniorCFO
Shelley CookHead of Operations & Alliance Manager
Patrik FoerchHead of Biology
Matthew FyfeHead of Chemistry & Intellectual Property
Tim SchmidtHead of Translational Research

Scientific Founders

Sitryx was founded by six world leading researchers in the field of immunometabolism, immunology and immunoregulation with the aim of building a biopharmaceutical company focused on the development of disease modifying therapeutics for treating inflammatory disorders and cancer.
Houman AshrafianSV Health Investors
Luke O’Neill FRSTrinity College Dublin
Jonathan PowellJohns Hopkins
Jeff RathmellVanderbilt
Michael RosenblumUCSF
Paul-Peter TakFounder, Independent Director